US 8252545
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
granted A61KA61K38/00A61P
Quick answer
US patent 8252545 (Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00, A61P37/02